Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)

SHE:300937 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	350.95	386.67	374.86	457.82	153.78	114.23
Short-Term Investments	-	4.12	0.83	-	-	-
Trading Asset Securities	-	1.5	4	7	-	-
Cash & Short-Term Investments	350.95	392.29	379.69	464.82	153.78	114.23
Cash Growth	-8.24%	3.32%	-18.32%	202.27%	34.62%	-7.25%
Accounts Receivable	394.12	250.81	196.54	146.26	57.75	59.38
Other Receivables	71.54	83.99	67.62	15.93	25.6	6.44
Receivables	465.66	334.79	264.16	162.18	83.35	65.82
Inventory	445.48	516.66	561.24	446.78	468.23	337.78
Prepaid Expenses	-	-	-	-	-	0.13
Other Current Assets	150.23	142.24	171.35	190.01	126.33	91.15
Total Current Assets	1,412	1,386	1,376	1,264	831.68	609.12
Property, Plant & Equipment	158.2	161.35	154.05	164.95	174.76	163.22
Long-Term Investments	50.13	45.19	28.25	22.4	21.58	17.56
Goodwill	16.57	16.57	16.47	16.36	2.52	3.13
Other Intangible Assets	46.36	47.64	46.43	50.65	42.06	39.23
Long-Term Deferred Tax Assets	23.56	25.45	15.23	8.86	3.69	3.03
Long-Term Deferred Charges	31.89	32.75	43.92	13.76	5.34	4.08
Other Long-Term Assets	1.26	1.57	6.27	50.83	105.43	-
Total Assets	1,740	1,717	1,687	1,592	1,187	839.38
Accounts Payable	438.53	332.9	359.66	370.54	184.1	208.43
Accrued Expenses	11.42	32.07	31.98	22.19	10.98	7.2
Short-Term Debt	328.57	372.32	320.74	235.84	119.36	40.05
Current Portion of Leases	11.4	6.77	4.2	5.24	4.7	-
Current Income Taxes Payable	8.34	6.14	4.99	7.87	1.19	3.16
Current Unearned Revenue	38.8	49.82	53.57	78.85	29.77	21.02
Other Current Liabilities	33.71	37.93	25.98	32.18	27.9	18.3
Total Current Liabilities	870.78	837.94	801.12	752.7	378	298.15
Long-Term Leases	10.64	9.76	4.69	2.54	5.75	-
Long-Term Unearned Revenue	4.6	4.68	5	6.32	6.1	6.43
Long-Term Deferred Tax Liabilities	12.27	13.08	13.34	10.07	9.29	9.58
Other Long-Term Liabilities	-	0.35	6.88	-	-	-
Total Liabilities	898.29	865.81	831.02	771.64	399.13	314.15
Common Stock	95.67	95.67	95.67	95.67	95.67	71.75
Additional Paid-In Capital	474	474.01	474.01	475.62	475.56	231.26
Retained Earnings	284.04	279.86	284.55	244.15	202.28	215.02
Comprehensive Income & Other	-	-	-	-1.5	-	-
Total Common Equity	853.72	849.54	854.22	813.94	773.51	518.02
Minority Interest	-11.73	1.16	1.82	6.03	14.43	7.21
Shareholders' Equity	841.99	850.69	856.04	819.98	787.94	525.23
Total Liabilities & Equity	1,740	1,717	1,687	1,592	1,187	839.38
Total Debt	350.62	388.85	329.63	243.62	129.8	40.05
Net Cash (Debt)	0.33	3.44	50.06	221.21	23.98	74.19
Net Cash Growth	-	-93.14%	-77.37%	822.60%	-67.68%	-10.80%
Net Cash Per Share	0.00	0.04	0.52	2.32	0.26	1.03
Filing Date Shares Outstanding	95.67	95.67	95.67	95.67	95.67	71.75
Total Common Shares Outstanding	95.67	95.67	95.67	95.67	95.67	71.75
Working Capital	541.53	548.04	575.32	511.1	453.68	310.98
Book Value Per Share	8.92	8.88	8.93	8.51	8.09	7.22
Tangible Book Value	790.79	785.33	791.32	746.94	728.93	475.66
Tangible Book Value Per Share	8.27	8.21	8.27	7.81	7.62	6.63
Buildings	-	116.61	116.57	118.19	117.76	-
Machinery	-	94.01	82.31	81.99	78.87	-
Construction In Progress	-	0.5	2.21	1.84	-	-

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.